A Novartis innovation, largely driven by Slovenian expertise, has received the national Gold Innovation Award from the Chamber of Commerce and Industry of Slovenia (GZS). The awarded solution addresses one of the key challenges facing the modern pharmaceutical industry and has potential beyond a single medicine.
The award-winning innovation is the result of collaboration between the teams at ChemOps Mengeš and Ljubljana Solids. A multidisciplinary team of Novartis experts developed an important technical improvement to the manufacturing process of medicine for the treatment of breast cancer, addressing the challenge of managing nitrosamine impurities in medicines. The solution meets the highest regulatory, safety and quality standards.
Innovation is particularly valuable because of its broader potential. The solution represents an important advancement not only for one medicine, but also opens up opportunities for application in the development of new medicines and contributes to the continued excellence of Novartis development and manufacturing processes.
The national Gold Innovation Award is an important recognition of the expertise, collaboration and dedication of our teams. It also demonstrates that solutions to complex scientific and technological challenges with broader potential are being developed in Slovenia.
Novartis experts among Slovenia’s leading innovators
The Chamber of Commerce and Industry of Slovenia is presenting its Innovation Awards for the 26th consecutive year. Novartis experts in Slovenia are regular recipients of both regional and national awards, with their creativity, expertise and dedication placing them among the country’s leading innovators. Their achievements reflect a long-standing culture of scientific excellence and a spirit of innovation and collaboration that are an integral part of Novartis identity.
